聚类触发的碳氧甲基β-环氧素粉末和片剂的排放
Xintong Li1, Haiyan Xu1, Hongyan Zhao1
1Zhejiang Sci-Tech University, College of Textile Science and Engineering (International Institute of Silk), CHINA.
ChemPlusChem
|May 13, 2025
概括
将非传统的发光剂压缩成平板电脑,可以增强它们的光发射特性. 这项研究揭示了压缩的碳甲基β-环氧化 (CM-β-CD) 中增加的分子相互作用可以改善光发光量子产量和持久的室温光.
科学领域:
- 材料科学 材料科学 材料科学
- 摄影化学的使用.
- 超分子化学 超分子化学
背景情况:
- 非传统的发光剂为细胞成像和防伪提供了潜力.
- 低光发光量子产量 (PLQY) 和弱持久室温光 (p-RTP) 限制了它们的应用.
- 平板电脑压缩是一种增强光原性能的有前途的方法,但潜在的机制需要阐明.
研究的目的:
- 研究平板电脑压缩增强非传统发光剂的发光特性的机制.
- 为了证明碳甲基β-环氧化 (CM-β-CD) 作为本研究的模型化合物的有效性.
- 探索压缩CM-β-CD在细胞成像和防伪方面的潜在应用.
主要方法:
- 样品制备:将碳甲基β-环氧化 (CM-β-CD) 粉末压缩成片.
- 特性:测量光发光量子产量 (PLQY) 和持续室温光 (p-RTP) 的寿命.
- 机械学研究:通过压缩诱导的分子相互作用和聚合行为的分析.
主要成果:
- 与粉末形式相比,药片形成显著改善了CM-β-CD的PLQY和p-RTP寿命.
- 在压缩片中观察到增强的分子相互作用和增加的平均包装密度.
- 该研究确定了聚类触发的排放和平均包装密度促进的排放作为负责改善发光的关键机制.
- 压缩的CM-β-CD在细胞成像和防伪应用中表现出有效的性能.
结论:
- 平板电脑压缩是一种有效的策略,可以增强CM-β-CD等非传统发光剂的发光特性.
- 增强的分子相互作用和聚合是改善PLQY和p-RTP的主要驱动因素.
- 压缩的CM-β-CD显示出对细胞成像和安全加密的先进应用具有重大前景.
相关概念视频
Intramolecular Claisen Condensation of Dicarboxylic Esters: Dieckmann Cyclization
2.3K
Dieckmann cyclization is an intramolecular Claisen condensation of diesters. The reaction occurs in the presence of a base and generates a cyclic β-ketoester as the final product. Commonly, 1, 6 and 1, 7-diesters are preferred substrates for the reaction since the generated five, and six-membered cyclic β-keto esters are particularly more stable.
2.3K
Factors Influencing Drug Absorption: Pharmaceutical Parameters
102
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
102
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
257
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
257


